科研成果详情

题名MUL1 identified as mitochondria-linked biomarker promoting cisplatin resistance in OC cells
作者
发表日期2024-12-20
发表期刊Gene   影响因子和分区
语种英语
原始文献类型Article
关键词OC MUL1 TCGA Platinum resistance Organoid culture
其他关键词E3 UBIQUITIN LIGASE ; CANCER STATISTICS ; INHIBITION ; METABOLISM ; APOPTOSIS
摘要Ovarian cancer (OC) ranks among the prevalent tumors affecting the female reproductive system. The aim of this study was to evaluate mitochondria-associated platinum resistance genes using organoid models. Univariate Cox regression, LASSO and multivariate Cox regression analyses were performed on The Cancer Genome Atlas (TCGA) database to construct 2-gene prognostic signature (MUL1 and SSBP1), and GSE26712 dataset was used for external validation. In addition, the relationship between MUL1 and platinum resistance was examined by organoid culture, lentiviral transduction, CCK8 assay, and Western blot. The results showed that patients in the high-risk group exhibited significantly worse OS (P = 0.002, P = 0.017). Drug sensitivity analysis revealed that platinum resistance increased with the upregulation of MUL1 expression (Cor = 0.5154, P = 0.02). Our experimental findings demonstrated that knockout of the MUL1 gene significantly increased apoptosis and enhanced the sensitivity of the OC cell line A2780 to cisplatin. Through this study, we have provided strong evidence for further research on prognostic risk factors and individualized treatment in OC patients, and provided new insights into addressing platinum resistance in OC.
资助项目Science and Technology Programs of Ningbo [KY2021-013]; Medical and Health Science and Technology Program of Zhejiang Province, China [202003N4289]; Science and Technology Programs of Wenzhou [2021440659]; Provincial natural Science Foundation of Zhejiang [Y2020090]
出版者ELSEVIER
ISSN0378-1119
EISSN1879-0038
卷号930
DOI10.1016/j.gene.2024.148841
页数10
WOS类目Genetics & Heredity
WOS研究方向Genetics & Heredity
WOS记录号WOS:001296822300001
收录类别SCIE ; SCOPUS ; PUBMED
URL查看原文
PubMed ID39134101
SCOPUSEID2-s2.0-85201302516
通讯作者地址[Guan, Yutao]Ningbo Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Ningbo, Zhejiang, Peoples R China. ; [Yan, Xiaojian]Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China. ; [Zhang, Jinsan]Wenzhou Med Univ, Dept Med Res Ctr, Wenzhou, Zhejiang, Peoples R China. ; [Zhang, Jinsan]Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm Med, Wenzhou, Zhejiang, Peoples R China.
Scopus学科分类Genetics
SCOPUS_IDSCOPUS_ID:85201302516
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/217417
专题附属第一医院
附属第一医院_产科
附属第一医院_呼吸内科
其他_附属第五医院(丽水市中心医院)
通讯作者Zhang, Jinsan; Guan, Yutao; Yan, Xiaojian
作者单位
1.Ningbo Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Ningbo, Zhejiang, Peoples R China;
2.Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China;
3.Wenzhou Med Univ, Dept Med Res Ctr, Wenzhou, Zhejiang, Peoples R China;
4.Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm Med, Wenzhou, Zhejiang, Peoples R China;
5.Wenzhou Med Univ, Zhejiang Univ, Lishui Hosp, Affiliated Hosp 5,Affiliated Cent Hosp Lishui, Lishui 323000, Peoples R China;
6.Wenzhou Peoples Hosp, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China
通讯作者单位附属第一医院;  产科;  温州医科大学;  呼吸内科
推荐引用方式
GB/T 7714
Liu, Lixiao,Zou, Chengyang,Shen, Jingtian,et al. MUL1 identified as mitochondria-linked biomarker promoting cisplatin resistance in OC cells[J]. Gene,2024,930.
APA Liu, Lixiao., Zou, Chengyang., Shen, Jingtian., Huang, Rong., Zhang, Fubin., ... & Yan, Xiaojian. (2024). MUL1 identified as mitochondria-linked biomarker promoting cisplatin resistance in OC cells. Gene, 930.
MLA Liu, Lixiao,et al."MUL1 identified as mitochondria-linked biomarker promoting cisplatin resistance in OC cells".Gene 930(2024).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Liu, Lixiao]的文章
[Zou, Chengyang]的文章
[Shen, Jingtian]的文章
百度学术
百度学术中相似的文章
[Liu, Lixiao]的文章
[Zou, Chengyang]的文章
[Shen, Jingtian]的文章
必应学术
必应学术中相似的文章
[Liu, Lixiao]的文章
[Zou, Chengyang]的文章
[Shen, Jingtian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。